We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+25.89%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$374M
AUM Growth
+$16.3M
(+4.5%)
Cap. Flow
-$27.9M
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
27.08%
Holding
761
New
59
Increased
126
Reduced
253
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI China ETF
MCHI
|
+$10.6M |
| 2 |
iShares MSCI South Africa ETF
EZA
|
+$7.66M |
| 3 |
iShares MSCI Malaysia ETF
EWM
|
+$6.49M |
| 4 |
UBS Group
UBS
|
+$5.93M |
| 5 |
Linde
LIN
|
+$5.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RSX
VanEck Russia ETF
RSX
|
+$10.6M |
| 2 |
iShares MSCI Turkey ETF
TUR
|
+$10.5M |
| 3 |
VanEck Gold Miners ETF
GDX
|
+$9.79M |
| 4 |
iShares MSCI Poland ETF
EPOL
|
+$8.27M |
| 5 |
Merck
MRK
|
+$3.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.93% |
| 2 | Financials | 11.29% |
| 3 | Healthcare | 10.43% |
| 4 | Consumer Discretionary | 8.19% |
| 5 | Communication Services | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Thermo Fisher Scientific
TMO
$214B
| $1.38M | 0.37% |
3,796
+868
| +30% | +$291K |
|
77
Bank of America
BAC
$429B
| $1.32M | 0.35% |
55,736
-5,272
| -9% | -$125K |
|
78
BCE
BCE
$20.8B
| $1.32M | 0.35% |
31,960
+19,000
| +147% | +$782K |
|
79
McDonald's
MCD
$193B
| $1.3M | 0.35% |
7,074
-1,935
| -21% | -$355K |
|
80
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.67B
| $1.28M | 0.34% |
84,000
+40,000
| +91% | +$587K |
|
81
S&P Global
SPGI
$124B
| $1.24M | 0.33% |
3,769
| – | – |
|
82
Adobe
ADBE
$105B
| $1.24M | 0.33% |
2,852
-1,445
| -34% | -$535K |
|
83
Broadcom
AVGO
$1.76T
| $1.18M | 0.32% |
37,440
-3,190
| -8% | -$89.3K |
|
84
JD.com
JD
$43.5B
| $1.15M | 0.31% |
19,079
-318
| -2% | -$16.1K |
|
85
Bristol-Myers Squibb
BMY
$129B
| $1.09M | 0.29% |
18,582
-2,968
| -14% | -$178K |
|
86
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| $1.05M | 0.28% |
+3,400
| New | +$995K |
|
87
American Airlines Group
AAL
$9.82B
| $1.03M | 0.28% |
78,854
-50,305
| -39% | -$610K |
|
|
88
PUT
Linde
LIN
$236B
| $940K | 0.25% |
1,380
-198
| -13% | -$38.2K |
|
89
Akamai
AKAM
$15.6B
| $933K | 0.25% |
8,714
+8,700
| +62,143% | +$875K |
|
90
CALL
Snap
SNAP
$7.96B
| $933K | 0.25% |
1,000
| – | – |
|
91
PUT
TechnipFMC
FTI
$28.6B
| $904K | 0.24% |
1,075
-1,371
| -56% | -$7.99K |
|
92
Citigroup
C
$213B
| $884K | 0.24% |
17,305
+4,438
| +34% | +$211K |
|
93
iShares MSCI Brazil ETF
EWZ
$8.98B
| $881K | 0.24% |
30,619
+730
| +2% | +$19.1K |
|
|
94
VanEck Gold Miners ETF
GDX
$22.5B
| $864K | 0.23% |
23,549
-297,620
| -93% | -$9.79M |
|
95
Verizon
VZ
$197B
| $861K | 0.23% |
15,614
+1,500
| +11% | +$84.4K |
|
|
BZUN
96
Baozun
BZUN
$179M
| $819K | 0.22% |
21,307
+13,666
| +179% | +$429K |
|
97
NVIDIA
NVDA
$4.6T
| $798K | 0.21% |
84,040
-114,480
| -58% | -$926K |
|
98
Apple
AAPL
$4.97T
| $792K | 0.21% |
+8,688
| New | +$673K |
|
99
SLB Ltd
SLB
$72.7B
| $784K | 0.21% |
42,620
+18,113
| +74% | +$317K |
|
|
100
CALL
Linde
LIN
$236B
| $773K | 0.21% |
555
-161
| -22% | -$31.1K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2020 Portfolio in Review
As of Q2 2020, Exane Derivatives held 761 positions worth $374M, up 4.5% from $358M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Exane Derivatives withdrew a net $27.9M in Q2 2020, closing 72 positions and reducing 253 holdings. Its most notable exit was iShares MSCI Turkey ETF, an estimated $10.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Exane Derivatives opened a new position in iShares MSCI South Africa ETF worth $8.2M.
- Exane Derivatives's largest Q2 2020 buy was iShares MSCI South Africa ETF: 232,582 shares worth $8.2M.
- Exane Derivatives added most to iShares MSCI China ETF in Q2 2020, an estimated $10.6M increase.
- Exane Derivatives's biggest Q2 2020 reduction was VanEck Russia ETF, cutting an estimated $10.6M.
- Exane Derivatives fully exited iShares MSCI Turkey ETF in Q2 2020, selling an estimated $10.5M.
- Exane Derivatives's ten largest holdings make up 27% of its $374M portfolio in Q2 2020.
- Exane Derivatives opened 59 new positions and closed 72 in Q2 2020.
- Exane Derivatives's portfolio value rose 4.5% quarter-over-quarter to $374M.
Based on Exane Derivatives's 13F filing for Q2 2020, filed 10 Jul 2020.